Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) CEO Grigorios Siokas acquired 62,500 shares of the stock in a transaction that occurred on Wednesday, January 15th. The shares were bought at an average price of $0.80 per share, for a total transaction of $50,000.00. Following the purchase, the chief executive officer now directly owns 4,087,727 shares of the company’s stock, valued at approximately $3,270,181.60. This trade represents a 1.55 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Grigorios Siokas also recently made the following trade(s):
- On Monday, January 13th, Grigorios Siokas purchased 163,666 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.61 per share, with a total value of $99,836.26.
- On Friday, December 20th, Grigorios Siokas acquired 257,334 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.58 per share, for a total transaction of $149,253.72.
Cosmos Health Price Performance
NASDAQ:COSM opened at $0.86 on Friday. The company has a quick ratio of 1.24, a current ratio of 1.44 and a debt-to-equity ratio of 0.08. The business’s 50-day moving average price is $0.71 and its 200 day moving average price is $0.91. Cosmos Health Inc. has a 52-week low of $0.47 and a 52-week high of $1.58. The firm has a market cap of $19.94 million, a P/E ratio of -0.35 and a beta of 5.57.
About Cosmos Health
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
Featured Articles
- Five stocks we like better than Cosmos Health
- Energy and Oil Stocks Explained
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- How to Invest in Biotech Stocks
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.